Mesoblast Limited Operating Expenses | MESO

Annual Operating Expenses Mesoblast Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	86.7 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
86.7 M	86.7 M	86.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Aprea Therapeutics APRE	13.5 M	$ 0.68	0.16 %	$ 4.45 M	USA
Aptevo Therapeutics APVO	-31.8 M	$ 1.8	2.27 %	$ 568 K	USA
Aquestive Therapeutics AQST	89.7 M	$ 4.57	0.44 %	$ 489 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 14.66	12.51 %	$ 401 M	Israel
Ardelyx ARDX	95.9 M	$ 3.39	1.5 %	$ 817 M	USA
argenx SE ARGX	3.19 B	$ 912.87	1.28 %	$ 56 B	Niderland
Armata Pharmaceuticals ARMP	41.5 M	$ 3.66	3.98 %	$ 133 M	USA
Arcutis Biotherapeutics ARQT	305 M	$ 25.15	0.04 %	$ 3.2 B	USA
Artelo Biosciences ARTL	11.4 M	$ 3.51	0.54 %	$ 664 K	USA
Arvinas ARVN	381 M	$ 7.46	0.67 %	$ 529 M	USA
Arrowhead Pharmaceuticals ARWR	731 M	$ 62.35	0.12 %	$ 8.34 B	USA
Assembly Biosciences ASMB	84.4 M	$ 22.74	0.89 %	$ 255 M	USA
Ascendis Pharma A/S ASND	338 M	$ 228.03	0.07 %	$ 13.8 B	Danmark
Actinium Pharmaceuticals ATNM	36.3 M	$ 1.2	2.56 %	$ 37.4 M	USA
Atossa Therapeutics ATOS	37.1 M	$ 2.45	4.7 %	$ 21.1 M	USA
Atara Biotherapeutics ATRA	344 M	$ 9.4	1.16 %	$ 118 M	USA
Aurinia Pharmaceuticals AUPH	43.9 M	$ 15.72	0.49 %	$ 2.11 B	Canada
Autolus Therapeutics plc AUTL	145 M	$ 1.83	2.81 %	$ 487 M	Britain
Atea Pharmaceuticals AVIR	181 M	$ 5.13	0.18 %	$ 418 M	USA
Anavex Life Sciences Corp. AVXL	51.4 M	$ 1.65	0.43 %	$ 141 M	USA
Axon Enterprise AXON	1.72 B	$ 411.81	0.69 %	$ 32.2 B	USA
Axsome Therapeutics AXSM	99.1 M	$ 177.08	0.73 %	$ 8.81 B	USA
Aytu BioScience AYTU	45.1 M	$ 2.04	1.45 %	$ 25.1 M	USA
BridgeBio Pharma BBIO	304 M	$ 66.14	0.51 %	$ 12.7 B	USA
BioCardia BCDA	15.7 M	$ 1.09	4.81 %	$ 7.27 M	USA
BioCryst Pharmaceuticals BCRX	144 M	$ 8.1	0.31 %	$ 1.7 B	USA
Bicycle Therapeutics plc BCYC	320 M	$ 4.01	18.64 %	$ 278 M	Britain
Black Diamond Therapeutics BDTX	57.5 M	$ 1.94	2.65 %	$ 110 M	USA
Beam Therapeutics BEAM	523 M	$ 25.67	4.78 %	$ 2.54 B	USA
Biogen BIIB	5.39 B	$ 223.59	1.69 %	$ 32.8 B	USA
BioVie BIVI	18.1 M	$ 1.44	0.68 %	$ 2.13 M	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.32	0.43 %	$ 5.72 B	Israel
BioMarin Pharmaceutical BMRN	1.47 B	$ 57.54	0.63 %	$ 11 B	USA
Bristol-Myers Squibb Company BMY	12.2 B	$ 58.81	0.53 %	$ 120 B	USA
Benitec Biopharma BNTC	51.2 M	$ 9.23	2.78 %	$ 430 M	USA
BioNTech SE BNTX	512 M	$ 97.64	0.76 %	$ 23.6 B	Germany
Burford Capital Limited BUR	181 M	$ 3.55	0.51 %	$ 778 M	Britain
BeyondSpring BYSI	40.3 M	$ 0.79	2.12 %	$ 32.5 M	USA
Cabaletta Bio CABA	172 M	$ 2.08	4.0 %	$ 209 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 2.14	0.45 %	$ 3.52 M	Israel
Capricor Therapeutics CAPR	108 M	$ 7.78	0.11 %	$ 362 M	USA
Catalyst Biosciences CBIO	105 M	$ 13.94	0.42 %	$ 1.25 B	USA
C4 Therapeutics CCCC	151 M	$ 2.99	1.36 %	$ 248 M	USA
Codexis CDXS	31.5 M	$ 1.39	2.21 %	$ 121 M	USA
Cerus Corporation CERS	149 M	$ 2.34	2.63 %	$ 446 M	USA
Certara CERT	237 M	$ 10.07	7.59 %	$ 1.62 B	USA
Cullinan Management CGEM	242 M	$ 16.04	3.42 %	$ 966 M	USA
Compugen Ltd. CGEN	32.2 M	$ 2.31	0.43 %	$ 216 M	Israel
Coherus BioSciences CHRS	231 M	$ 1.12	0.86 %	$ 131 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 32.59	2.97 %	$ 2.16 B	USA